Clinical Trial Update: Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating QL1101 and Avastin in combination with paclitaxel and carboplatin as first-line therapy for non-squamous non-small cell lung cancer h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Non-squamous Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• QL1101 (bevacizumab biosimilar)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Non-squamous Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED